News for hackers. Stuff that matters.

A comment on Anti-addiction drug maker found a captive market in the criminal justice system. Parent comment

Re:Anti-addiction drug maker found a captive market in the c... by leggomylibro on Friday June 30, 2017 @03:55PM (#14673266)
The active ingredient's $2 market price includes the markups for R&D, failed previous projects, etc that are inherent in drug development. Repackaging an existing generic hardly merits the same.
[ Parent | on HN ]
Re:Anti-addiction drug maker found a captive market in the c... by c3534l on Friday June 30, 2017 @06:16PM (#14673887)
> The active ingredient's $2 market price includes the markups for R&D

Not if it's generic, it doesn't. The cost of R&D has to be paid off during the patent period. Also, to call it "repackaged" is disingenuous. The delivery method is what's being charged for.

[ Parent | on HN ]
Re:Anti-addiction drug maker found a captive market in the c... by aisofteng on Friday June 30, 2017 @08:57PM (#14674616)
It's not disingenuous, it's just (probably) incorrect. Why does "disingenuous" get used so much around here? It's almost never used correctly.
[ Parent | on HN ]
Re:Anti-addiction drug maker found a captive market in the c... by c3534l on Friday June 30, 2017 @09:59PM (#14674890)
I felt like he was reframing things to the point where it was no longer true. I think he knows that the new version is an extended release injection (I mean, it was mentioned explicitly in the article), but he said "repackaged" for rhetorical reasons.
[ Parent | on HN ]